Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1383–1393. doi: 10.1158/1055-9965.EPI-21-1227

Table 3:

Distribution of treatment, availability and accessibility characteristics for OC patients by race (N=9,726)

Variable Non-Hispanic White Non-Hispanic Black Hispanic
N 8,474 672 580
Received primary debulking surgery 3,297 (38.9) 190 (28.2) 208 (35.9)
Primary debulking surgery performed by Gyn/Onc 2,099 (29.4) 115 (20.8) 129 (27.5)
Recommended systemic therapy initiation 4,608 (68.3) 301 (58.6) 304 (68.0)
AVAILABILITY
No primary physician identified 206 (2.4) 32 (4.8) 22 (3.8)
Saw Gyn/Onc at least once 4,608 (54.4) 299 (44.5) 270 (46.5)
Primary physician specialty
 Gynecologic Oncology 1,943 (22.9) 158 (23.5) 118 (20.3)
 HemeOnc/MedOnc 3,901 (46.0) 246 (36.6) 266 (45.9)
 Ob-Gyn 485 (5.7) 53 (7.9) 33 (5.7)
 Internal Medicine 1357 (16.0) 119 (17.1) 101 (17.4)
 Other 582 (6.9) 64 (9.5) 40 (6.9)
 No physician 206 (2.4) 32 (4.8) 22 (3.8)
Treatment facility affiliated with medical school
 Affiliated 4,200 (49.5) 410 (61.0) 291 (25.3)
Treatment facility ownership
 Non-profit 6236 (73.6) 482 (71.7) 413 (71.1)
 Proprietary <750 α <75 α <70 α
 Government 1502 (17.7) 123 (18.3) 104 (17.9)
 Missing <11α <11 α <11α
Treatment facility NCI cancer center status
 No 7,710 (91.0) 618 (92.0) 515 (88.8)
 Yes 740 (8.7) >50 α >60 α
 Missing 24 (0.3) <11 α <11 α
Treatment facility critical access status
 No 8,062 (95.1) 657 (97.8) >540 α
 Yes 388 (4.6) 15 (2.2) <11 α
 Missing 24 (0.3) 0 (0) <11 α
Treatment facility: number of beds
 <100 1,231 (14.4) <65 α <65 α
 100–200 1,315 (15.5) 108 (16.1) 106 (18.3)
 200+ 5,898 (69.6) 507 (75.4) 415 (71.5)
 Missing 30 (0.3) <11α <11α
Treatment facility: highest quartile OC surgical volume 2,165 (25.5) 143 (21.3) 118 (20.3)
ACCESSIBILITY
Distance from patient zip code to facility zip code
 0–5 miles 3,410 (40.2) 307 (45.7) 254 (43.8)
 5–10 miles 2,016 (23.8) 166 (24.7) 131 (22.6)
 10–20 miles 1,532 (18.1) 102 (15.2) 93 (16.0)
 20–50 miles 897 (10.6) 61 (9.1) 60 (10.3)
 50+ miles 594 (7.0) <40α <45α
 Missing 25 (0.3) <11α <11α
α

Value anonymized to enhance confidentiality by suppressing small cell sizes.

Abbreviations: obstetrician-gynecologist (Ob-Gyn); ovarian cancer (OC); gynecologic oncologist (Gyn/Onc); National Cancer Institute (NCI); hematologist oncologist (HemeOnc); medical oncologist (MedOnc).